These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4614451)

  • 1. [Assessment of a new coagulation test in liver disease: normotest].
    Hadchouel P; Touboul JP; Caroli J
    Sem Hop Ther; 1974; 50(7-8):459-62. PubMed ID: 4614451
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the correlation between Normotest, Quick's method, and specific coagulation factors in liver disease.
    Hadchouel P; Touboul JP; Caroli J
    Scand J Gastroenterol Suppl; 1973; 19():151-4. PubMed ID: 4515639
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostasis and liver disease.
    Mannucci PM; Mari D
    Haematologica; 1981 Apr; 66(2):233-48. PubMed ID: 6792002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Fischer P; Reinelt D
    Z Gesamte Inn Med; 1968 Jun; 23(12):Suppl:177-9. PubMed ID: 5687435
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of Normotest and antithrombin 3 in the assessment of liver function.
    Mannucci L; Dioguardi N; Del Ninno E; Mannucci PM
    Scand J Gastroenterol Suppl; 1973; 19():103-7. PubMed ID: 4515631
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of plasma fibrinolytic activity in chronic disorders of the liver and biliary tract].
    Pstruzinová H; Jablonská M; Richter V; Pstruzina J
    Sb Lek; 1971 Apr; 73(4):89-98. PubMed ID: 5552779
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
    Pagliano FM; Cestari G; Slucca P
    Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

  • 10. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new system of analysis for partial thromboplastin time. Comparison with other blood coagulation tests in liver diseases].
    Pagliano FM; Slucca P; Cestari G
    Arch Sci Med (Torino); 1976; 133(4):321-5. PubMed ID: 1023840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostasis disorders in liver diseases].
    Rosiek B
    Pol Tyg Lek; 1974 Jun; 29(25):1097-100. PubMed ID: 4601905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
    Moscarella S; Ventimiglia V
    Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of abnormal preoperative hemostatic tests.
    Bowie EJ; Owen CA
    Prog Hemost Thromb; 1980; 5():179-209. PubMed ID: 6775346
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance and practicability of Normotest in diagnosis of chronic liver diseases.
    Henning H; Yano M
    Scand J Gastroenterol Suppl; 1973; 19():119-23. PubMed ID: 4515634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serological studies on antigamma-globulin factors in liver diseases].
    Meyer zum Büschenfelde ; Hopf U; Bokisch V
    Acta Hepatosplenol; 1968; 15(2):78-88. PubMed ID: 4174702
    [No Abstract]   [Full Text] [Related]  

  • 17. Prothrombin antigen and coagulant activity in patients with liver disease.
    Corrigan JJ; Jeter M; Earnest DL
    JAMA; 1982 Oct; 248(14):1736-9. PubMed ID: 7120594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites.
    Imawari M; Akanuma Y; Itakura H; Muto Y; Kosaka K; Goodman DS
    J Lab Clin Med; 1979 Jan; 93(1):171-80. PubMed ID: 569678
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum proteins in diseases of the liver.
    Skrede S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Clin Lab Invest; 1975 Sep; 35(5):399-406. PubMed ID: 52885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood serum lipid content in chronic liver diseases].
    Loginov AS; Markova MN; Zelikina NS
    Ter Arkh; 1972 Jul; 44(7):40-5. PubMed ID: 5069976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.